Subscribe to Search results

Professor Tedder raised a concern that ELISA-positive but RIBA-negative samples might contain the virus.

Published on:

Dr Rejman wrote to Dr Gunson regarding steps to be taken regarding Hepatitis C testing in advance of the next ACVSB meeting.

Published on:

Dr Contreras wrote to colleagues at the North London Blood Transfusion Centre and Dr Gunson to protest that the proposed procedure for supplementary testing counselling and referral was "extremely complicated and astronomically expensive."

Published on:

The Working Group on Plasma Fractions met and noted that "Evidence of the value of the Chiron test for non-A non-B hepatitis is not yet available in this country. Future developments will be watched with much interest."

Published on:

Virologists Drs Mortimer, Tedder, Follett and others met to agree proposed arrangements to be put in place for confirmatory testing at three reference laboratories.

Published on:

Dr Gunson's proposals for pilot studies in Birmingham, Sheffield and Brentwood to the NHS Procurement Directorate were agreed and the studies took place over a two-week period in early December.

Published on:

Dr Gunson wrote to RTC directors in England and Wales informing them the Department of Health had agreed that routine anti-HCV testing could be put into operation.

Published on:

Dr Metters wrote a memo suggesting that the next ACVSB meeting should be brought forward and solely devoted to the question of whether routine anti-HCV screening of blood donations should commence.

Published on:

Dr Gunson's revised "Report on the Meeting in Rome to Discuss Chiron Testing" was submitted to the ACVSB. It added that every effort must be made to ensure that a confirmatory test was available in the UK at the time routine donor screening was introduced.

Published on:

Dr Gunson and Violet Rawlinson produced a report regarding the first months of anti-HCV testing.

Published on:

Funding was agreed and a commencement for HCV testing in July was likely.

Published on:

At an East Anglia Blood Transfusion Centre meeting, Professor Allain said he would prefer to introduce routine testing at an early date.

Published on:

At a meeting of the NBTS' Northern Division, Dr Gunson described extending the original valuation study.

Published on:

Dr Gunson presented the results of the pilot study to a meeting of the National Management Committee of the NBTS and undertook to prepare a more comprehensive report for the ACVSB.

Published on:

Professor Zuckerman spoke of a specific test for non-A non-B Hepatitis being "awaited with breathless anticipation", thereby conveying both the importance of developing such a test and the urgency of doing so.

Published on:

The Ortho assay was published in "Science" and was evaluated internationally from that date onwards.

Published on:

"The Lancet" carried two letters on the topic of "Screening for Hepatitis C Virus Antibody", the first from Dr Contreras and Dr Barbara and the second from Professor Cash.

Published on:

Dr Barbara went to the Paris meeting and regarded the test as "reproducible, robust and meaningful".

Published on:

Brown and Thomas published "Blood Transfusion Services Should Have Begun Screening for Hepatitis C When an Antibody Assay First Became Available" in "Reviews in Medical Virology".

Published on:

Dr Lloyd wrote to Professor Cash reiterating his concern that the UK was "dragging its feet over testing" and was running the risk of "accepting the lowest common denominator" approach.

Published on: